[EXPERIENCE IN THE TREATMENT OF MALIGNANT DISEASES OF THE RETICULOENDOTHELIAL SYSTEM AND LEUKEMIAS. II].
D001623:Betamethasone; D002066:Busulfan; D002699:Chlorambucil; D003300:Copper; D003520:Cyclophosphamide; D003907:Dexamethasone; D040181:Genetic Diseases, X-Linked; D007501:Iron / Q000378:metabolism*; D007938:Leukemia; D007943:Leukemia, Hairy Cell; D007945:Leukemia, Lymphoid; D008206:Lymphatic Diseases; D008903:Minerals / Q000378:metabolism*; D012157:Mononuclear Phagocyte System; D009101:Multiple Myeloma; D009369:Neoplasms; D011241:Prednisone; D055728:Primary Myelofibrosis; D011878:Radiotherapy; D016511:Severe Combined Immunodeficiency; D013266:Stilbamidines; D014520:Urethane; D015032:Zinc
D008903:Minerals; D013266:Stilbamidines; D002699:Chlorambucil; D014520:Urethane; D003300:Copper; D003907:Dexamethasone; D003520:Cyclophosphamide; D001623:Betamethasone; D007501:Iron; D002066:Busulfan; D015032:Zinc; D011241:Prednisone
BETAMETHASONE; BUSULFAN; CHLORAMBUCIL; COPPER; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IRON METABOLISM; LEUCOSARCOMA; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; MINERAL METABOLISM; MULTIPLE MYELOMA; MYELOID METAPLASIA; PREDNISONE; RADIOTHERAPY; RETICULOENDOTHELIOSIS; STILBAMIDINES; URETHANE; ZINC
ERVARINGEN BIJ DE BEHANDELING VAN MALIGNE AANDOENINGEN VAN HET RETICULO-ENDOTHELIALE SYSTEEM EN LEUKEMIUEN. II.